Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02843555 · ClinicalTrials.gov registry record
Natural History of the Leukodystrophies
A clinical trial of Leukodystrophies, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT02843555 is a study of Leukodystrophies that has completed, run by Baylor Research Institute. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02843555, a study of Leukodystrophies, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to: 1. define novel homogeneous groups of patients with LDs and 2. work toward finding the cause of these disorders.
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-01-23 |
| Est. Completion | 2019-01-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02843555
The ClinicalTrials.gov registry entry for NCT02843555 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Leukodystrophies appearing as the primary indexed condition, and to 0 interventions.
NCT02843555 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02843555 about?
NCT02843555 is a clinical study titled "Natural History of the Leukodystrophies". The purpose of this study is to: 1. define novel homogeneous groups of patients with LDs and 2. work toward finding the cause of these disorders.
What is the current status of trial NCT02843555?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2019-01-23. Estimated completion is 2019-01-23.
What conditions does trial NCT02843555 study?
This clinical trial studies the following conditions: Leukodystrophies.
Who is sponsoring clinical trial NCT02843555?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02843555 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.